News Articles
Sector/Industry
Please Select
Company
24 October, 2024
Telix Pharmaceuticals' Brain Cancer Imaging Agent Receives Priority Review from FDA
In a significant milestone for Australian biotech, Telix Pharmaceuticals Limited (ASX: TLX) has announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA)...
24 October, 2024
Memphasys’ Felix™ Clinical Trial Nears Completion as CE Mark Strategy Speeds European Market Entry
Australian biotech company Memphasys Limited (ASX: MEM) is closing in on a key milestone with its Felix™ System clinical trial, which is now 90% complete. With fewer than 20 patients left to recruit,...
22 October, 2024
Adisyn Ltd (ASX: AI1) Powers Up: 2D Generation Acquisition Set to Supercharge AI Revolution
In a bold move, Adisyn Ltd (ASX: AI1) has shifted its relationship with Israeli graphene innovator 2D Generation (2DG) into high gear, announcing its proposed acquisition of the semiconductor IP...
18 October, 2024
MTM Critical Metals to Present at COSM Summit: Tech Giants to Witness E-Waste Revolution
MTM Critical Metals Ltd (ASX: MTM) has been invited to present its groundbreaking Flash Joule Heating (FJH) technology at the prestigious COSM Technology Summit in Seattle, USA. The event is a...
17 October, 2024
Memphasys Gears Up for Felix™ Commercialisation in the Equine Fertility Market
Memphasys Limited (ASX: MEM) is racing towards commercialising its Felix™ System, a technology designed to revolutionise the equine fertility market. Following promising initial trials, the company...